Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Rheumatology

Does Treating Acne or PPP Prevent SAPHO Bone Flares?

At a Glance

Treating acne or palmoplantar pustulosis may improve skin symptoms but has not been shown to prevent SAPHO bone flares. Skin and bone activity can follow separate patterns, so doctors monitor and treat each area and investigate new or worsening bone pain.

Controlling your skin symptoms is essential for your comfort and quality of life, but there is no good evidence that treating your acne or palmoplantar pustulosis (PPP) will prevent or eliminate SAPHO bone flares [1]. While they are part of the same syndrome, your skin and bone activity often do not match. Improvement in your skin does not guarantee that your skeleton is protected from inflammation.

The Disconnect Between Skin and Bone Activity

In SAPHO syndrome, skin manifestations and bone issues can sometimes start at the exact same time [2]. However, it is very common for symptoms to emerge on different timelines as the disease progresses [3]. It can be frustrating to manage a condition where symptoms do not always move together, but understanding this disconnect is key to getting the right care.

Medical research suggests that the bone and joint symptoms of SAPHO and the skin symptoms may involve overlapping but partly independent mechanisms [1]. Because of this, treating one does not automatically fix the other:

  • Differing Treatment Responses: Case studies show that certain medications might successfully clear the skin but fail to improve joint and bone pain, or vice versa [4].
  • Changes on Imaging: Even when a patient feels better and their symptoms improve, scans can still show areas of bone change [5]. These persistent imaging abnormalities may represent old structural changes or remodeling rather than currently active inflammation. Furthermore, increased bone activity seen on scans does not always strongly correlate with how much pain a person is feeling [6].

Targeting Treatments

Because skin and bone flares do not necessarily influence each other, you and your doctors cannot assume that clearing your skin is enough to protect your bones. Each domain often requires its own targeted approach.

Treating the Bones and Joints

  • NSAIDs: Doctors often recommend non-steroidal anti-inflammatory drugs (NSAIDs) to manage bone and joint pain [7]. Safety Note: Do not self-start, combine, or continue NSAIDs without medical advice. They only relieve symptoms rather than preventing flares, and they carry risks for people with kidney disease, stomach ulcers, cardiovascular disease, or those who are pregnant.
  • Bisphosphonates: For prominent bone inflammation (osteitis) or abnormal bone thickening (hyperostosis), drugs that alter bone turnover (bisphosphonates) may be considered in selected patients [8]. The evidence for their use comes largely from small observational studies, and they are often used off-label. Your doctor should review specific safety considerations, including kidney and dental health, before starting them.

Treating the Skin

Dermatologic treatments depend on which skin condition you have, and should be managed by a dermatologist:

  • For Severe Acne: Treatments may include specific antibiotics or oral medications like isotretinoin [9]. Note that isotretinoin can have musculoskeletal side effects, making careful monitoring important for SAPHO patients.
  • For Palmoplantar Pustulosis (PPP): Treatments often involve potent topical therapies, phototherapy, or systemic retinoids like acitretin [10].
    There is no good evidence that these skin-directed treatments prevent or heal SAPHO bone inflammation [9].

Dual-Target Systemic Therapies

For refractory or extensive disease, doctors might selectively prescribe conventional disease-modifying antirheumatic drugs (DMARDs) or biologics [11] [1]. While some of these drugs can improve both skin and musculoskeletal symptoms [12], this happens because the medication acts on both areas directly—not because clearing the skin caused the bones to heal [4]. These medications are often used off-label, their evidence in SAPHO is limited, and they carry important risks, including increased chances of infection.

Coordinating Your Care and Monitoring

Managing SAPHO effectively requires your rheumatologist and dermatologist to work together [7] [1].

Your care team should monitor your skin and bones separately. While skin checks track acne and PPP, bone inflammation requires clinical assessments of pain, swelling, and stiffness [13]. Imaging, such as an MRI, is generally obtained when it will answer a specific diagnostic or management question; routine or serial MRIs are not automatically required for every patient. By tracking both domains independently, your medical team can ensure you get comprehensive relief.

What to Monitor

Keep a symptom diary tracking your skin activity alongside the location, duration, and severity of your bone and joint symptoms. However, always contact your doctor promptly for clinical assessment if you experience:

  • New or worsening severe bone pain
  • Significant swelling or stiffness
  • Fever
  • An inability to use an affected joint

Do not wait for your next scheduled skin review to bring up new skeletal symptoms.

Common questions in this guide

Will treating SAPHO-related acne or palmoplantar pustulosis stop bone flares?
There is no good evidence that treating acne or palmoplantar pustulosis prevents or heals SAPHO bone inflammation. Skin improvement can occur while bone inflammation continues, because skin and bone activity may follow partly independent patterns.
Why can my skin improve while my SAPHO bone pain continues?
The skin and musculoskeletal features of SAPHO syndrome can respond differently to treatment and may flare at different times. A medication that clears acne or palmoplantar pustulosis may not control bone or joint inflammation.
What treatments may be used for SAPHO bone inflammation?
Doctors may use nonsteroidal anti-inflammatory drugs to relieve bone and joint pain, while bisphosphonates may be considered for selected cases involving osteitis or hyperostosis. More extensive or persistent disease may require a disease-modifying drug or biologic, but evidence is limited and these medicines require medical supervision.
Can one SAPHO medication help both my skin and bone symptoms?
Some disease-modifying antirheumatic drugs and biologic medicines may improve both skin and musculoskeletal symptoms. When this happens, the medicine is acting on both areas directly; clearing the skin does not itself cause the bones to heal. These treatments may be used off-label and can carry important risks, including infection.
Do I need an MRI to check whether my SAPHO bone inflammation is active?
An MRI or other imaging is generally used when it can answer a specific diagnostic or treatment question, not automatically for routine monitoring of every patient. Doctors also consider pain, swelling, stiffness, examination findings, and whether scan changes may reflect older remodeling rather than active inflammation.
What should I do if my skin improves but my SAPHO bone pain gets worse?
Tell your doctor promptly rather than waiting for your next skin appointment, because skin improvement does not rule out active bone disease. Seek prompt clinical assessment for new or worsening severe bone pain, significant swelling or stiffness, fever, or inability to use an affected joint.

Get notified when new evidence is published on SAPHO syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    New Insights in the Treatment of SAPHO Syndrome and Medication Recommendations.

    Cheng W, Li F, Tian J, et al.

    Journal of inflammation research 2022; (15()):2365-2380 doi:10.2147/JIR.S353539.

    PMID: 35444448
  2. 2

    Serum interleukin-23 protects, whereas methotrexate treatment stimulates selected components of the metabolic syndrome in patients with SAPHO syndrome.

    Przepiera-Będzak H, Fischer K, Brzosko M

    Archives of medical science : AMS 2021; (17(1)):120-126 doi:10.5114/aoms.2018.76953.

    PMID: 33488864
  3. 3

    SAPHO: Treatment options including bisphosphonates.

    Zwaenepoel T, Vlam K

    Seminars in arthritis and rheumatism 2016; (46(2)):168-173 doi:10.1016/j.semarthrit.2016.04.004.

    PMID: 27369452
  4. 4

    Successful treatment of SAPHO syndrome with apremilast.

    Adamo S, Nilsson J, Krebs A, et al.

    The British journal of dermatology 2018; (179(4)):959-962 doi:10.1111/bjd.16071.

    PMID: 29034454
  5. 5

    Long-term remarkable remission of SAPHO syndrome in response to short-term systemic corticosteroids treatment in an immunoglobulin E elevated patient: A case report.

    Wang L, Li C, Yu M, et al.

    Medicine 2019; (98(27)):e16045 doi:10.1097/MD.0000000000016045.

    PMID: 31277098
  6. 6

    F-18 FDG PET/CT in 26 patients with SAPHO syndrome: a new vision of clinical and bone scintigraphy correlation.

    Sun X, Li C, Cao Y, et al.

    Journal of orthopaedic surgery and research 2018; (13(1)):120 doi:10.1186/s13018-018-0795-0.

    PMID: 29788984
  7. 7

    Treatment and monitoring of SAPHO syndrome: a systematic review.

    Li SWS, Roberts E, Hedrich C

    RMD open 2023; (9(4)) doi:10.1136/rmdopen-2023-003688.

    PMID: 38151265
  8. 8

    SAPHO syndrome: a review.

    Rukavina I

    Journal of children's orthopaedics 2015; (9(1)):19-27 doi:10.1007/s11832-014-0627-7.

    PMID: 25585872
  9. 9

    SAPHO syndrome with acne fulminans and severe polyosteitis involving axial skeleton.

    Divya BL, Rao PN

    Indian dermatology online journal 2016; (7(5)):414-417 doi:10.4103/2229-5178.190495.

    PMID: 27730042
  10. 10

    Successful treatment of SAPHO syndrome (chronic nonbacterial osteomyelitis and acne) with anakinra and denosumab. Case report and review of therapy.

    Adam Z, Šedivá A, Zeman D, et al.

    Vnitrni lekarstvi 2023; (69(E-5)):4-14 doi:10.36290/vnl.2023.065.

    PMID: 37827817
  11. 11

    The effectiveness of treatments for patients with SAPHO syndrome: a follow-up study of 24 cases from a single center and review of literature.

    Huang H, Zhang Z, Zhao J, et al.

    Clinical rheumatology 2021; (40(3)):1131-1139 doi:10.1007/s10067-020-05322-x.

    PMID: 32789818
  12. 12

    Upadacitinib in the treatment of SAPHO syndrome: a case report.

    Yang Y, Sun Z, Ge Y

    Frontiers in immunology 2025; (16()):1662675 doi:10.3389/fimmu.2025.1662675.

    PMID: 41341579
  13. 13

    [Diagnosis and treatment of chronic nonbacterial osteitis (CNO) and SAPHO syndrome : Implications of the current consensus recommendations of an international commission of experts for German rheumatology].

    Assmann G, Klemm PCM, Hedrich C, et al.

    Zeitschrift fur Rheumatologie 2026; (85(2)):93-105 doi:10.1007/s00393-025-01741-w.

    PMID: 41313366

This page is for informational purposes only and does not constitute medical advice. Ask your rheumatologist and dermatologist how to monitor and treat your SAPHO skin and bone symptoms.